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INTRODUCTION
In humans, CC chemokines (CCLs) and their speci c CC receptors (CCRs) play a central role in physiological and pathological recruitment of immune cells 9, 24 . During infectious diseases, the expression of CCLs and CCRs produces a chemotactic gradient between regional lymph nodes and infected tissues where, depending on the pattern of CCLs and/or CCRs expressed, specific dendritic cells and T lymphocytes are chemoattracted. Thus, it is established a cellular pathway that goes both ways, in which 1) dendritic cells migrate toward lymphoid organs to present microbial antigens and 2) activated T helper (Th) lymphocytes migrate toward infected tissues to accomplish their speci c immunological function 24 .
Th lymphocytes play a central role in the pathogenesis of periodontitis, and a Th1 and Th17dominated immuno-in ammatory response has been associated with periodontal tissue destruction, alveolar bone resorption, and teeth loss. In this context, the pattern of CCLs and CCRs expressed by Th lymphocytes is crucial in the establishment of the local Th-pattern of immuno-in ammatory response and in the outcome of the disease 9, 28 . In fact, greater levels of CCL3, CCL4, CCL5, CCL28, CCR1, CCR5, and CCR9 were detected in periodontal lesions of aggressive periodontitis patients, and increased levels of CCL2 and CCR4 were found in lesions of chronic periodontitis patients 8, 23 . In addition, increased production of IF -has been associated with both greater expression of CCR5 and differentiation of Th1 lymphocytes 16 . Similarly, increased production of IL-6 and IL-23 has been associated with both greater expression of CCL2, CCR6, and CCR7, and subsequent differentiation, migration, and activation of Th17 lymphocytes 13, 15 . Conversely, increased production of IL-4 and IL-10 has been demonstrated to inhibit the production of CCR5 and to induce the expression of CCL11, CCR3, and CCR4, implied in the Th2 lymphocyte differentiation and function 18 .
Recently, our research group has reported a differential immunogenicity when dendritic cells and T lymphocytes were stimulated with the different serotypes of A. actinomycetemcomitans 2, 3 . In particular, when T lymphocytes were stimulated with autologous monocyte-derived dendritic cells primed with the serotype b of A. actinomycetemcomitans, higher levels of Th1-and Th17-associated transcription factors and cytokines were detected compared with similar experiments with the other serotypes, demonstrating that serotype b strains of A. actinomycetemcomitans have a higher capacity of triggering Th1 and Th17 phenotype and function. It is, therefore, the aim of this investigation to elucidate whether the different serotypes of A. actinomycetemcomitans have a role on the differential expression of CCLs and CCRs. We hypothesized that the serotype b of A. actinomycetemcomitans, when used to stimulate T lymphocytes, induces higher Th1-and Th17-associated CCL and CCR expression when compared with the other A. actinomycetemcomitans serotypes.
MATERIAL AND METHODS

Experimental design
This experimental study consisted of cell cultures of peripheral naïve CD4 + T lymphocytes obtained from healthy humans and infected in vitro with A. actinomycetemcomitans. The protocol of the study was clearly explained to all the participants, who agreed to participate in it by signing an institutional review board-approved informed consent (Protocol 2010/14). The study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2000.
A. actinomycetemcomitans strains
The A. actinomycetemcomitans strains ATCC ® 43717™ (serotype a), ATCC ® 43718™ (serotype b), and ATCC ® 43719™ (serotype c) were cultured on agar brain-heart infusion medium (Oxoid, Hampshire, UK) at 37°C and under capnophilic conditions (8% O 2 and 12% CO 2 ) using an appropriate microaerobic condition generator (CampyGen™; Oxoid, Hampshire, UK). Growth curves were obtained, and live bacteria, having their whole antigenic potentiality, were obtained at the exponential growth phase of the bacterial culture and used for in vitro cell stimulation.
Blood donors
Blood cells were obtained during plateletapheresis process from healthy donors consecutively enrolled at the Blood Bank of the Hospital Del Salvador in the Eastern Metropolitan Health Service. The study group consisted of 12 adult individuals (seven males and ve females, aged 21 to 38 years, mean age of 28.3±5.10 years) who did not have periodontal disease as determined by absence of gingival in ammation, clinical attachment loss, or increased probing depths (PD>3 mm). Further exclusion criteria were the positive test for HIV and hepatitis B or C virus, presence of manifest infections during the last month, fever, symptomatic allergies, abnormal blood cell counts, increased liver enzymes, or medication of any kind except vitamins and oral contraceptives.
Monocyte-derived dendritic cell generation
For each subject, peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation using standard procedures (Ficoll-Paque Plus; GE Healthcare, Uppsala, Sweden). For generating a puri ed population of immature dendritic cells, monocytes were purified from PBMCs by magnetic cell sorting separation (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). Brie y, PBMCs were incubated with an anti-CD14 monoclonal antibody conjugated to magnetic beads for 15 min at 4°C, loaded onto LS columns and then separated in the magnetic eld of a cell separator (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). The retained CD14 + cells, which correspond to monocytes, were then ushed out and washed twice in phosphate-buffered saline. Monocytes were then immediately differentiated to dendritic cells by culturing at 10 6 cells/mL in RPMI-1640 medium supplemented with 10% foetal calf serum (Gibco Invitrogen Corp., Grand Island, NY, USA) and 20 ng/mL rhGM-CSF and rhIL-4 (R&D Systems Inc., Minneapolis, MN, USA) for 6 d at 37°C.
T-lymp ocyte p ri cation
A puri ed population of naïve CD4 + T lymphocytes was obtained from PBMCs by magnetic cell sorting depletion (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). Brie y, both non-T helper and memory T helper cells were depleted using a cocktail of biotin-conjugated monoclonal antibodies (CD8, CD14, CD15, CD16, CD19, CD25, CD34, CD36, CD45RO, CD56, CD123, TCR / , HLA-DR, and CD235a) and anti-biotin monoclonal antibodies conjugated to magnetic beads. The magnetically labelled cells were retained within LD columns in the magnetic eld of a cell separator (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany), while the unlabelled naïve CD4 + T lymphocytes ran through.
Cell stimulation
Monocyte-derived dendritic cells were primed at a multiplicity of infection MOI=10 2 (bacteria/cells ratio) with different serotypes of A. actinomycetemcomitans, and then 10 6 T-lymphocytes/mL were activated with primed autologous dendritic cells (50:1) in culture with RPMI-1640 containing 10% foetal calf serum (Gibco Invitrogen Corp., Grand Island, NY, USA) for 5 d at 37°C. Previous to each cell co-culture, dendritic cells were washed twice with RPMI-1640 supplemented with 50 IU/mL penicillin and 50 g/ mL streptomycin ( MI, USA). T-lymphocyte cultures devoid of dendritic cells or exposed to non-induced autologous dendritic cells were used for comparisons. In each experimental step, dendritic cell and T-lymphocyte counting was performed with a hemocytometer and using a phase contrast microscopy (Axiovert 100; eiss Co., G ttingen, Germany), and cell viability equal to or higher than 95% was calculated by Trypan blue dye exclusion. For each individual, the experiment was performed separately.
Phenotypic cell analysis
T-lymphocyte puri cation and their subsequent activation were analyzed by ow cytometry (BD FACSCanto™; Becton Dickinson Immunocytometry Systems, San José, CA, USA). Cells were stained using the following monoclonal antibodies conjugated with uorescein isothiocyanate (FITC) or phycoerythrin (PE): anti-CD4 (CD4 + T-lymphocytes), anti-CD25 (activated CD4 + T-lymphocytes), anti-CD45RA (naïve CD4 + T-lymphocytes), and anti-CD45RO (memory CD4 + T-lymphocytes) following the manufacturer's recommendations (BD Biosciences Pharmingen, San José, CA, USA). Isotype-matched control monoclonal antibodies were used to determine the negative cell populations.
Expression of CD25 , CCR, CCL, and transcription factor mRNAs
From activated T lymphocytes, total cytoplasmic RNA was isolated using 400 μl of ice-cold lysis buffer containing 0.5% Igepal ® CA-630 (Sigma-Aldrich, Saint Louis, MO, USA), 50 mM Tris-HCl pH8, 100 mM NaCl, 5 mM MgCl 2 , and 10 mM VRC-40 (Gibco Invitrogen, Carlsbad, CA, USA). Isolated RNA was quanti ed using a spectrophotometer (Synergy HT; Bio-Tek Instrument Inc., Winooski, VT, USA), and the rst-strand cDNA was synthesized using 5 μg of total RNA with a SuperScrip ™ III reverse transcription kit, following the manufacturer's instructions (Invitrogen, Grand Island, NY, USA). The mRNA expression levels for the chemokines CCL1, CCL2, CCL3, CCL5, CCL11, CCL17, CCL20, CCL21, CCL25, and CCL28, the chemokine receptors CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 and the transcription factors T-bet (Th1), GATA-3 (Th2), RORC2 (Th17), and Foxp3 (T-regulatory), as well as for the activated T-lymphocyte marker CD25 , were quanti ed by qPCR using the appropriate primers ( Figure 1 ). Brie y, 50 ng of cDNA were ampli ed using a KAPA ™ SYBR ® Fast qPCR reagent (KAPA Biosystems, Woburn, MA, USA) in a StepOnePlus ® equipment (Applied Biosystems, Singapore) as follows: 95°C for 3 min, followed by 40 cycles of 95°C for 3 s, and 60°C for 30 s, and nally a melt curve of 95°C for 15 s, 60°C for 1 min, and 95°C for 15 s, for detection of non-speci c product formation and false positive ampli cation. As an endogenous control, 18S rRNA expression levels were determined.
Data analysis
The ow cytometry data were analyzed using the WinMDi 2.9 software (The Scripps Research Institute, La Jolla, CA, USA), represented as histograms, and expressed as the percentage of positive cells over the total. The qPCR data were analyzed using the StepOne Software 2.2.2 (Applied Biosystems, Singapore) and presented in fold-change of relative quantities by normalizing the CD25 , CCR, CCL, or transcription factor mRNA expression to 18S rRNA expression using the 2 -Ct method. Data were statistically analyzed using the SPSS 15.0 software (Lead Technologies Inc., Charlotte, NC, USA). The normality of data distribution was determined using the Kolmogorov-Smirnov test. Differences regarding CD expression levels analyzed by ow cytometry were determined using the chi-square test. Differences among groups and within each group regarding the CD25 , CCR, CCL, and transcription factor mRNA expression were analyzed using the Kruskal-Wallis test or ANOVA and Tukey post-hoc tests. Correlation coef cients were obtained using the Pearson or Spearman tests. Asterisks were used to graphically indicate statistical signi cance. A value of p 0.05 was considered statistically signi cant.
RESULTS
T-lymphocyte puri cation and activation
For this study, highly puri ed (>98%) populations of naïve CD4 + T lymphocytes (CD4 + CD25 -CD45RA + CD45RO -), devoid of activated or memory CD4 + T lymphocytes, were isolated from peripheral blood of healthy donors (Figure 2A ). These T lymphocytes activated at a similar extent upon stimulation with dendritic cells primed with the different serotypes of A. actinomycetemcomitans, as shown by the similar signi cant over-expression in CD25 mRNA levels (p<0.001) compared with T lymphocytes exposed to non-induced dendritic cells ( Figure 2B) . These similar levels of T lymphocyte activation were con rmed at a protein level when the cell-surface expression of CD25 was determined by ow cytometry. In fact, the frequency of CD25 expression (~15%) in T lymphocytes exposed to the different serotypes of A. actinomycetemcomitans did not differ signi cantly ( Figure 2C ).
E x p r e s s i o n o f C C L s b y A . a c t i n o m y c e t e m c o m i t a n s -i n d u c e d T lymphocytes
The mRNA expression for the analyzed chemokines was determined by qPCR and represented as fold- (Figure 3 ). When the strain ATCC ® 43718™ belonging to the serotype b of A. actinomycetemcomitans was used for T-lymphocyte activation, higher expression levels of CCL2 (p=0.025 and p=0.024), CCL3 (p=0.003 and p=0.005), CCL5 (p=0.004 and p=0.013), CCL20 (p=0.05 and p=0.02), CCL21 (p=0.001 and p=0.001), and CCL28 (p=0.004 and p=0.008) were detected, when compared with the strains ATCC ® 43717™ and ATCC ® 43719™ belonging to the serotypes a or c, respectively. Conversely, when the serotype a of A. actinomycetemcomitans was used for T-lymphocyte activation, higher expression levels of CCL1 (p=0.008 and p=0.009) and CCL17 (p>0.05 and p>0.05) were detected, when compared with the serotypes b or c, respectively. CCL11 and CCL25 were not over-expressed in any experimental condition.
E x p r e s s i o n C C R s b y A . a c t i n o m y c e t e m c o m i t a n s -i n d u c e d T lymphocytes
The mRNA expression for the analyzed chemokine receptors was determined by qPCR and represented as fold-change for each condition (Figure 4 ). When the serotype b of A. actinomycetemcomitans was used for T-lymphocyte activation, higher expression levels of CCR1 (p=0.036 and p=0.026), CCR2 (p=0.041 and p=0.042), CCR5 (p=0.029 and p=0.035), CCR6 (p=0.045 and p=0.044), CCR7 (p=0.039 and p=0.020), CCR9 (p=0.040 and p=0.035), and CCR10 (p=0.018 and p=0.022) were detected compared with the serotypes a or c, respectively. Conversely, when the serotype a of A. actinomycetemcomitans was used for T-lymphocyte activation, higher expression levels of CCR3 (p=0.006 and p=0.007), CCR4 (p>0.05 and p>0.05), and CCR8 (p>0.05 and p>0.05) were detected, when compared with the serotypes b or c, respectively.
Expression of T-bet, GATA-3, RORC2, and Foxp3 by A. actinomycetemcomitansinduced T lymphocytes
The mRNA expression for T-bet, GATA-3, RORC2, and Foxp3 was determined by qPCR in T lymphocytes stimulated by dendritic cells primed at a MOI=10 2 with the different serotypes of A. actinomycetemcomitans ( Figure 5 ). Similarly to our previous experiments 2 , T lymphocytes stimulated with the serotype b showed a higher relative expression of T-bet (p<0.001 and p<0.001) and RORC2 (p<0.001 and p=0.001) mRNAs than the same cells stimulated with the serotypes a or c, respectively.
Figure 3-CC chemokines (CCL) expression by A. actinomycetemcomitans-induced
T lymphocytes. CCL mRNA expression in T lymphocytes activated by dendritic cells primed at a MOI=10 2 with the A. actinomycetemcomitans strains ATCC ® 43717™ (serotype a), ATCC ® 43718™ (serotype b), and ATCC ® 43719™ (serotype c). For relative expression, the CCL mRNA expression in T lymphocytes exposed to non-induced dendritic cells was considered as 1, as a reference for fold-change in expression (n.i). Data are represented as fold-change for 8 independent experiments. Each experiment was performed in duplicate. Comparisons were done between the different A. actinomycetemcomitans serotypes (*p<0.05) 
Differential expression of CC chemokines (CCLs) and receptors (CCRs) by human T lymphocytes in response to different
Correlation analysis between T-bet, GATA-3, RORC2, and Foxp3 versus CCL and CCR expression levels
The correlation analyses between the expression of the transcription factors and the CCLs and CCRs on each activation condition tested (Table 1) yielded positive correlation between T-bet and CCL2, CCL3, CCL5, CCL25, CCR1, CCR2, CCR5, and CCR9, being statistically signi cant for CCL5 (p=0.049), CCR1 (p=0.040), and CCR2 (p=0.046), when T lymphocytes were stimulated with the serotype b of A. actinomycetemcomitans. Under the same condition, a positive correlation was also observed between RORC2 and CCL20, CCL21, CCR6, and CCR7, being statistically significant for CCL20 (p=0.041), CCL21 (p=0.004), and CCR7 (p=0.030). In contrast, GATA-3 showed positive correlation with CCL1, CCL17, CCR3, CCR4, and CCR8, being statistically signi cant for CCL1 (p=0.049), CCL17 (p=0.046), CCR4 (p=0.002), and CCR8 (p=0.048) when T lymphocytes were stimulated with the
Figure 4-CC receptors (CCR) expression by A. actinomycetemcomitans-induced
T lymphocytes. CCR mRNA expression in T lymphocytes activated by dendritic cells primed at a MOI=10 2 with the A. actinomycetemcomitans strains ATCC ® 43717™ (serotype a), ATCC ® 43718™ (serotype b), and ATCC ® 43719™ (serotype c). For relative expression, the CCR mRNA expression in T lymphocytes exposed to non-induced dendritic cells was considered as 1, as a reference for fold-change in expression (n.i). Data are represented as fold-change for 8 independent experiments. Each experiment was performed in duplicate. Comparisons were done between the different A. actinomycetemcomitans serotypes (*p<0.05) serotype a of A. actinomycetemcomitans and with CCR8 (p=0.044) when the same cells were stimulated with the serotype c. Foxp3 did not show positive correlation with any CCL or CCR (data not shown). Overall, a T-lymphocyte response biased towards a Th1-and Th17-pattern of CCL and CCR expression was detected under stimulation with the serotype b of A. actinomycetemcomitans.
DISCUSSION
There is strong evidence suggesting that variations in the host immuno-inflammatory response, in particular, in the T lymphocyte phenotype and function, play an important role in the susceptibility, onset, and severity of periodontitis 6, 10 . In particular, a Th1 and Th17-dominated immunoin ammatory response has been associated with the pathogenesis of periodontitis, and an increased expression of Th1-and Th17-related transcription factors and pro-in ammatory mediators have been reported in active periodontal lesions, where alveolar bone resorption is occurring 6, 17 . In this study, the expression levels of different CCLs and CCRs were analyzed in human naïve T lymphocytes, stimulated with dendritic cells primed with different serotypes of A. actinomycetemcomitans, demonstrating that the serotype b induced greater expression levels of Th1-and Th17-associated CCLs and CCRs, when compared with the other serotypes.
The association between the serotype b of A. actinomycetemcomitans and the pathogenesis of the periodontitis has been previously analyzed 2, 3, 27, 30, 32 . In fact, the serotype b of A. actinomycetemcomitans triggers a greater immunogenic and pathogenic response when in contact with different host cells compared with the other serotypes. For instance, the serotype b induces increased resistance to phagocytosis and to killing by macrophages and neutrophils 32 , higher expression of IL-8 and ICAM-1 in gingival epithelial cells 27 , greater production of IL-1 in macrophages 30 , and stronger induction of Th1-and Th17-type of response in dendritic cells and CD4 + T lymphocytes 2,3 .
To our knowledge, this is the first report associating the different serotypes of A. actinomycetemcomitans with a Th1-and Th17pattern of immuno-inflammatory response by analyzing the CC chemokines and receptors involved in the selective chemo-attraction of Th lymphocytes. These ndings are suggestive of the pathogenic role of A. actinomycetemcomitans in the aetiology of periodontitis, which may differ among serotypes and speci cally let us propose that serotype b could play a role in the pathogenesis of the disease by the induction of a local in ammatory environment that favors the speci c recruitment of Th1 and Th17 lymphocytes towards the infected periodontal tissues.
In rheumatoid arthritis, which is an in ammatory disease characterized by the development of a Th1 and Th17-dominated immuno-in ammatory response in the affected articular tissues 14 , it has been established that the chronicity of the in ammation is associated with a Th1-and Th17pattern of CCL and CCR expression. In fact, in chronic in amed joints, over-expressed levels of CCL2, CCL3, CCL5, CCR1, CCR2, and CCR5, related to a Th1-type response 26,29 , and CCL20, CCL21, CCR6, and CCR7, related to a Th17-type response 14, 22 , have been detected compared with non-in amed joints. In addition, increased expression of CCL20 has been associated with predominant Th17 lymphocyte in ltration in the affected articular tissues 11 and, when the chemokine receptors CCR1, CCR2, CCR5, and CCR6 were blocked, a decreased Th1 lymphocyte migration towards the in amed joints was detected, promoting the resolution of the disease 11, 26 .
The results of the present study are consistent with the available scientific evidence, and demonstrate that a Th1-and Th17-pattern of immuno-in ammatory response develops during the periodontal infection, at least during an in vitro mono-infection with A. actinomycetemcomitans. Thus, the Th1 and Th17-dominated immunoin ammatory response described in periodontitis could be explained by the increased chemoattraction of recently activated and differentiated Th1 and Th17 lymphocytes from regional lymph nodes and/or by the activation of naïve and memory Th1 and Th17 lymphocytes residing in the periodontal tissues 12,25 . In this context, the serotype b of A. actinomycetemcomitans could be associated with local periodontal tissue destruction by the overproduction of Th1-and Th17-associated cytokines, such as IL1-, IL-6, IL-17A, and TNF-2,3 , and the over-expression of Th1-and Th17-associated CCLs and CCRs, such as CCL2, CCL3, CCL5, CCR1, CCR2, CCR5, and CCR7, as demonstrated in the present study, which are involved in the differentiation and activation of osteoclasts and the resorption of tooth-supporting alveolar bone [6] [7] [8] [9] 28 . In fact, a more frequent and higher expression of CCL2 and its speci c receptor CCR4 have been reported in chronic periodontitis, and a more prevalent and higher expression of CCL3 and its speci c receptor CCR5 have been reported in aggressive periodontitis 9 . Thus, the A. actinomycetemcomitans serotype b-induced Th1 and/or Th17 lymphocytes could migrate towards infected tissues following the CCL2 and/or CCL3 chemotactic gradient, resulting in a Th1 and/or Th17-associated cytokine production at the periodontal lesion that locally promote the alveolar bone resorption.
The A. actinomycetemcomitans strains used in the present study are phenotypically smooth. In fact, these different serotypes correspond to structurally distinct O-polysaccharide components of their respective LPS that function as immunodominant antigens. The O-polysaccharide from the LPS produced by the serotype b of A. actinomycetemcomitans is structurally distinct from the O-polysaccharide produced by the other serotypes. In particular, the O-polysaccharide from serotype b consists of a repeating trisaccharide unit composed of -D-fucose, -L-rhamnose and -D-N-acetyl-galactosamine residues, and the O-polysaccharide from serotypes a and c is composed of 6-deoxy--D-talose and 6-deoxy--L-talose, respectively 19,20 .
Interestingly, our data also show that serotype b of A. actinomycetemcomitans induces an increment in the CCR10 expression in stimulated T lymphocytes, a chemokine receptor associated with Th2 lymphocyte differentiation and function 31 . In this context, it has been demonstrated that CCR10 is also expressed by Th22 lymphocytes, a recently described T lymphocyte population that complies pro-in ammatory activities 5 ; however, this T-cell phenotype has not yet been described in periodontitis. Accordingly, it could be hypothesized that Th22 lymphocytes may be associated with the pathogenesis of periodontitis 1 , which would clarify, at least to a certain degree, the over-expressed levels of CCR10 and its speci c chemokine ligand CCL28 detected in the present study. In fact, higher levels of CCL28 have been detected in the gingival crevicular uid of chronic and aggressive periodontitis patients compared with gingivitis and healthy individuals 4 .
During periodontitis, antigen presentation may occur both in the regional lymph nodes that drain the periodontal tissues and locally in the infected periodontal tissues, in a periodontal site-speci c manner. In fact, formation of periodontal lymphoid clusters in which dendritic cells present bacterial antigens to naïve or memory T lymphocytes has been reported, promoting the activation and selective differentiation of Th1 and Th17 lymphocytes 12,25 . In this scenario, CCR7 and its speci c chemokine ligands CCL19 and CCL21 could play a role in the organization of these cellular clusters, as an ectopic lymphoid-like structure 21 , promoting the alveolar bone resorption characteristic of the periodontitis.
CONCLUSIONS
In T lymphocytes, the serotype b of A. actinomycetemcomitans induces higher expression levels of chemokines CCL2, CCL3, CCL5, CCL20, CCL21, and CCL28 and of chemokine receptors CCR1, CCR2, CCR5, CCR6, CCR7, and CCR9, when compared with the other serotypes. These increased levels associated with the expression of the transcription factors master-switch genes that trigger the Th1 and Th17 lymphocyte differentiation. Considered together, these data let us propose that variability in the Th1 and Th17 immuno-in ammatory response induced by the different serotypes of A. actinomycetemcomitans is associated, at least to a certain degree, with the CC chemokines and receptors that they express; however, functional studies are necessary to con rm our hypothesis.
